HMSTrust Laboratory to have global impact on health
Victorian Minister for Health the Hon. Jill Hennessy MP today opened a new research laboratory, placing Victoria at the forefront of global health research and development.
The Helen Macpherson Smith Trust HMSTrust Laboratory at the Monash Institute of Pharmaceutical Science (MIPS) will bring together Victorian research institutions, biotech and pharmaceutical organisations, creating a hub for research and development.
The HMSTrust Laboratory represents an exciting collaboration between equipment suppliers PerkinElmer and Shimadzu in this laboratory.
Ms Hennessy said the HMSTrust Laboratory would ensure Victoria and Monash University remain world leaders in global health.
“The creation of the HMSTrust Laboratory at the Monash Institute of Pharmaceutical Science is a shining example of Victorian research, development and infrastructure having a global impact,” Ms Hennessy said.
The genesis of this unique facility was a HMSTrust grant of $50,000 made in 2007 to MIPS for the purchase of an analytical separation system. This equipment, still in use today, enabled researcher, Associate Professor Michelle McIntosh, to develop the globally-recognised inhaled oxytocin project, which in turn became the catalyst for establishing this first-of-its-kind facility in Australia.
Dr Philip Moors AO, HMSTrust Chair, said the Trust was proud of its role in supporting Victorian researchers through the establishment of the HMSTrust Laboratory.
“Building capacity for the long term through collaboration and partnership are key objectives of the Trust, and we’re delighted that HMSTrust’s grant of $1.2 million has leveraged an additional $1.45 million in international funding and partnership,” Dr Moors said at today’s launch.
“Our shared vision is truly reflected in the laboratory’s slogan, Victorian ideas. Global impact.”
Professor Margaret Gardner AO, Monash University President and Vice-Chancellor, said the support of the HMSTrust and industry partners ensures Monash remains at the cutting edge of global health research and development.
“Over more than half a century Monash has forged a reputation as one of the world’s leading research institutions at the forefront of global health initiatives,” Professor Gardner said.
“Thanks to the generous support of the HMSTrust, PerkinElmer and Shimadzu, we have provided our researchers with world-class facilities to continue their life-changing work.”
The HMSTrust has distributed more than $100 million to Victorian charitable institutions in over 60 years. For more information on the HMSTrust Laboratory, visit: http://hmstrust.org.au/case-studies/monash-institute-pharmaceutical-sciences-mips/